SEC Form 4 · accession 0001104659-18-048858
CYPHERPUNK TECHNOLOGIES INC. · CYPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James H Cavanaugh
Director · 10% Owner
Period of report
Jul 30, 2018
Accepted (ET)
Aug 1, 2018 · 7:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509745
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy) | $6.085 | Jul 30, 2018 | J | 2,137 | A | Nov 14, 2017 | Nov 14, 2024 | Common Stock | 2,137 | 2,137 | D |
Explanation of responses
- F1Pro rata distribution from HealthCare Ventures IX, L.P., of which the reporting person is a limited partner. The reporting person is also a Managing Director of HealthCare Partners VIII, LLC, which is General Partner of HealthCare Partners VIII, L.P., which is the General Partner of HealthCare Ventures VIII, L.P. ("HCV VIII"). HCV VIII continues to hold 2,618,406 shares of common stock, representing 17.8% of the outstanding shares of common stock.